Atlas Trials

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19

Clinical trial NCT04373707 · COMPLETED

Trial details

NCT number
NCT04373707
Sponsor
Central Hospital, Nancy, France
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVIDThrombosisPulmonary EmbolismDeep Vein Thrombosis
Start date
2020-05-13
Primary completion
2021-04-29
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.